SCHEMBL845406

SCHEMBL845406

CC(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
MAPK1 P28482 2/20 0.52
GAA P10253 1/20 0.52
LMNA P02545 2/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ITGB1 P05556 5/20 0.50
ITGA4 P13612 5/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 1/20 0.49
CYP1A2 P05177 1/20 0.48
PABPC1 P11940 1/20 0.48
HTT P42858 1/20 0.48
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13272444 0.95 ALDH1A1 (0.56) ALDH1A1MAPK1LMNAITGB1ITGA4
SCHEMBL845205 0.95 ALDH1A1 (0.56) ALDH1A1MAPK1LMNAITGB1ITGA4
SCHEMBL845226 0.95 ALDH1A1 (0.56) ALDH1A1MAPK1LMNAITGB1ITGA4
SCHEMBL15116912 0.95 ALDH1A1 (0.56) ALDH1A1MAPK1LMNAITGB1ITGA4
SCHEMBL845111 0.95 ALDH1A1 (0.56) ALDH1A1MAPK1LMNAITGB1ITGA4
SCHEMBL1030175 0.95 ALDH1A1 (0.56) ALDH1A1MAPK1LMNAITGB1ITGA4
SCHEMBL845408 0.94 ALDH1A1 (0.54) ALDH1A1MAPK1LMNAITGB1ITGA4
SCHEMBL845154 0.94 ALDH1A1 (0.54) ALDH1A1MAPK1LMNAITGB1ITGA4
SCHEMBL845171 0.91 ALDH1A1 (0.53) ALDH1A1LMNAITGB1ITGA4KDM4E
SCHEMBL845160 0.91 HSD11B1 (0.53) ALDH1A1LMNAITGB1ITGA4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed